MarketCap
Facebook
X
Telegram
Amgen Total Non Current Liabilities | AMGN
Annual Total Non Current Liabilities Amgen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 37.2 B | 40.4 B | 45.7 B | 36.5 B | 34.8 B | 36.2 B | 36.1 B | 27 B | 24.1 B | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 45.7 B | 24.1 B | 35.3 B |
Total Non Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Dynavax Technologies Corporation
DVAX
|
218 M | - | - | $ 2.02 B |  USA |
 |
Alnylam Pharmaceuticals
ALNY
|
2.71 B | $ 159.75 | 5.35 % | $ 20.9 B | USA |
 |
Orgenesis
ORGS
|
12 M | - | -33.86 % | $ 61.2 M | USA |
 |
Codiak BioSciences
CDAK
|
119 M | - | -55.98 % | $ 2.15 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
2.06 B | $ 248.31 | 1.17 % | $ 15.1 B |  Irlanda |
 |
Johnson & Johnson
JNJ
|
62.3 B | $ 280.31 | -0.17 % | $ 675 B | USA |
 |
Kala Pharmaceuticals
KALA
|
26.2 M | $ 0.17 | 0.64 % | $ 1.39 M | USA |
 |
BioLineRx Ltd.
BLRX
|
5.44 M | $ 1.49 | -1.97 % | $ 3.67 B |  Israel |
 |
Sage Therapeutics
SAGE
|
27.4 M | - | - | $ 527 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.19 M | $ 1.59 | -2.76 % | $ 2.62 M | Israel |
 |
Lineage Cell Therapeutics
LCTX
|
5.05 M | $ 1.13 | 8.17 % | $ 260 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
255 M | - | - | $ 121 M | USA |
 |
TCR2 Therapeutics
TCRR
|
807 K | - | - | $ 58.1 M | USA |
 |
C4 Therapeutics
CCCC
|
69.5 M | $ 2.9 | -3.5 % | $ 240 M | USA |
 |
Eli Lilly and Company
LLY
|
50.7 B | $ 1 437.4 | 0.36 % | $ 1.29 T | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
24.8 M | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Compugen Ltd.
CGEN
|
31.3 M | $ 2.09 | -0.24 % | $ 195 M | Israel |
 |
Adverum Biotechnologies
ADVM
|
27.3 M | - | - | $ 86.2 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
4.9 M | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
GeoVax Labs
GOVX
|
14.7 K | $ 2.13 | -20.4 % | $ 2.04 M | USA |
 |
Unity Biotechnology
UBX
|
13.3 M | - | -33.41 % | $ 3.37 M | USA |
 |
MediciNova
MNOV
|
1.9 M | $ 1.41 | 0.36 % | $ 69.2 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
14.7 M | - | - | $ 521 M | USA |
 |
Seelos Therapeutics
SEEL
|
7.49 M | - | -47.76 % | $ 6.27 M | USA |
 |
Celldex Therapeutics
CLDX
|
4.83 M | $ 30.18 | -1.53 % | $ 2 B | USA |
 |
Moderna
MRNA
|
1.7 B | $ 248.62 | -0.88 % | $ 96.7 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
2.03 M | $ 3.96 | 1.41 % | $ 48.3 M | Israel |
 |
Nektar Therapeutics
NKTR
|
218 M | $ 38.41 | 1.67 % | $ 648 M | USA |
 |
Applied Molecular Transport
AMTI
|
106 M | - | - | $ 10.1 M | USA |
 |
CorMedix
CRMD
|
924 K | $ 5.31 | -2.23 % | $ 383 K | USA |
 |
CRISPR Therapeutics AG
CRSP
|
194 M | $ 45.39 | 0.53 % | $ 4.08 B |  Schweiz |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
908 K | $ 1.66 | -2.64 % | $ 1.12 B | Israel |
 |
Deciphera Pharmaceuticals
DCPH
|
15.9 M | - | - | $ 2.18 B | USA |
 |
Idera Pharmaceuticals
IDRA
|
127 M | - | -23.04 % | $ 26.6 M | USA |
 |
Tyme Technologies
TYME
|
4.89 M | - | 8.07 % | $ 54 M | USA |
 |
Akero Therapeutics
AKRO
|
1.52 M | - | - | $ 3.67 B | USA |
 |
Verona Pharma plc
VRNA
|
227 M | - | - | $ 69.7 B |  Britain |
 |
Oramed Pharmaceuticals
ORMP
|
12 M | $ 4.1 | 3.27 % | $ 170 M | Israel |
 |
Karuna Therapeutics
KRTX
|
150 K | - | - | $ 12.2 B | USA |
 |
Atreca
BCEL
|
12.6 M | - | -11.76 % | $ 5.79 M | USA |
 |
Curis
CRIS
|
62.5 M | $ 0.59 | -9.62 % | $ 7.77 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
38.9 M | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Fusion Pharmaceuticals
FUSN
|
4.31 M | - | - | $ 1.41 B |  Canada |
 |
Завод ДИОД
DIOD
|
89.5 M | - | - | - |  Russia |
 |
Gritstone Oncology
GRTS
|
30.5 M | - | 0.42 % | $ 213 M | USA |
 |
Pfizer
PFE
|
84.4 B | $ 29.42 | 0.19 % | $ 167 B | USA |
 |
HOOKIPA Pharma
HOOK
|
6.68 M | - | -6.92 % | $ 79.4 M | USA |